CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 8-K Event Executive or director change
- 8-K Event Material agreement
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 4/A Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
Page 29 of 83 · 1,649 filings